Hideji Hanabusa

Ogikubo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Long-term safety and efficacy of emicizumab in a phase 1/2 study in patients with hemophilia A with or without inhibitors.

Long-term safety and efficacy of emicizumab in a phase 1/2 study in patients with hemophilia A with or without inhibitors.

Journal: Blood advances

Published: March 13, 2017

Safety and efficacy of a glycoPEGylated rFVIII (turoctocog alpha pegol, N8-GP) in paediatric patients with severe haemophilia A.

Safety and efficacy of a glycoPEGylated rFVIII (turoctocog alpha pegol, N8-GP) in paediatric patients with severe haemophilia A.

Journal: Thrombosis and haemostasis

Published: March 10, 2017

Brief Report: The Impact of Ledipasvir/Sofosbuvir on HIV-Positive and HIV-Negative Japanese Hemophilia Patients With 1, 4, and Mixed-Genotype HCV.

Brief Report: The Impact of Ledipasvir/Sofosbuvir on HIV-Positive and HIV-Negative Japanese Hemophilia Patients With 1, 4, and Mixed-Genotype HCV.

Journal: Journal of acquired immune deficiency syndromes (1999)

Published: December 17, 2016

Analysis of the Japanese subgroup in LEOPOLD II: a phase 2/3 study of BAY 81-8973, a new recombinant factor VIII product.

Analysis of the Japanese subgroup in LEOPOLD II: a phase 2/3 study of BAY 81-8973, a new recombinant factor VIII product.

Journal: International journal of hematology

Published: August 08, 2016

A phase III clinical trial of a mixture agent of plasma-derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors.

A phase III clinical trial of a mixture agent of plasma-derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: June 16, 2016

Clinical evaluation of glycoPEGylated recombinant FVIII: Efficacy and safety in severe haemophilia A.

Clinical evaluation of glycoPEGylated recombinant FVIII: Efficacy and safety in severe haemophilia A.

Journal: Thrombosis and haemostasis

Published: June 10, 2016

Factor VIII-Mimetic Function of Humanized Bispecific Antibody in Hemophilia A.

Factor VIII-Mimetic Function of Humanized Bispecific Antibody in Hemophilia A.

Journal: The New England journal of medicine

Published: May 26, 2016

Acquired hemophilia A and fulminant diabetes mellitus possibly caused by adalimumab in a patient with psoriatic arthritis.

Acquired hemophilia A and fulminant diabetes mellitus possibly caused by adalimumab in a patient with psoriatic arthritis.

Journal: The Journal of dermatology

Published: May 22, 2016

Clinical efficacy of a combination of Percoll continuous density gradient and swim-up techniques for semen processing in HIV-1 serodiscordant couples.

Clinical efficacy of a combination of Percoll continuous density gradient and swim-up techniques for semen processing in HIV-1 serodiscordant couples.

Journal: Asian journal of andrology

Published: February 25, 2016

Nonacog beta pegol in previously treated children with hemophilia B: results from an international open-label phase 3 trial.

Nonacog beta pegol in previously treated children with hemophilia B: results from an international open-label phase 3 trial.

Journal: Journal of thrombosis and haemostasis : JTH

Published: December 24, 2015

Nonacog beta pegol (N9-GP) in haemophilia B: A multinational phase III safety and efficacy extension trial (paradigm™4).

Nonacog beta pegol (N9-GP) in haemophilia B: A multinational phase III safety and efficacy extension trial (paradigm™4).

Journal: Thrombosis research

Published: December 24, 2015

Recombinant long-acting glycoPEGylated factor IX (nonacog beta pegol) in haemophilia B: assessment of target joints in multinational phase 3 clinical trials.

Recombinant long-acting glycoPEGylated factor IX (nonacog beta pegol) in haemophilia B: assessment of target joints in multinational phase 3 clinical trials.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: December 18, 2015

Showing 1-12 of 22

Last Updated: 09/26/2026